Still, it is controversial the effect of the schedule of chemotherapy exposure in the expression of ABC transporters in retinoblastoma patients while a major impact is well documented in ovarian cancer cell lines and vascular endothelial cells[68,69]. The gene discussed is ABCG2; the disease is ovarian cancer.